Alkermes officials see bigger paydays – Boston Globe
By admin
|
Alkermes officials see bigger paydays
Boston Globe The Waltham biotechnology company yesterday reported that David A. Broecker, who resigned as chief executive in September 2009, earned $6.3 million in total … Alkermes to Host Conference Call to Discuss Financial Results for First …MarketWatch (press release) |
July 30th, 2010
This author published 8885 posts in this site.Share
Comments are closed.
Personalized Gene Medicine
| Mesenchymal Stem Cells
| Stem Cell Treatment for Multiple Sclerosis
| Stem Cell Treatments
| Board Certified Stem Cell Doctors
| Stem Cell Medicine
| Personalized Stem Cells Therapy
| Stem Cell Therapy TV
| Individual Stem Cell Therapy
| Stem Cell Therapy Updates
| MD Supervised Stem Cell Therapy
| IPS Stem Cell Org
| IPS Stem Cell Net
| Genetic Medicine
| Gene Medicine
| Longevity Medicine
| Immortality Medicine
| Nano Medicine
| Gene Therapy MD
| Individual Gene Therapy
| Affordable Stem Cell Therapy
| Affordable Stem Cells
| Stem Cells Research
| Stem Cell Breaking Research